PTC Therapeutics: A Balanced Hold Rating Amid Regulatory Challenges and Upcoming Milestones
TipRanksApr 26 19:55 ET
RBC Capital Sticks to Their Hold Rating for PTC Therapeutics (PTCT)
TipRanksApr 26 06:36 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Integer Holdings (ITGR), Resmed (RMD) and PTC Therapeutics (PTCT)
TipRanksApr 26 06:03 ET
Buy Rating Affirmed for PTC Therapeutics Amidst Strong Q1 Performance and Promising Pipeline Prospects
TipRanksApr 26 05:46 ET
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), PTC Therapeutics (PTCT) and Teladoc (TDOC)
TipRanksApr 26 05:27 ET
Sell Rating on PTC Therapeutics Amid Sustainability Concerns and Market Uncertainties
TipRanksApr 26 02:36 ET
PTC Therapeutics Analyst Ratings
BenzingaApr 12 09:53 ET
Analysts Offer Insights on Healthcare Companies: Syndax Pharmaceuticals (SNDX), Inozyme Pharma (INZY) and PTC Therapeutics (PTCT)
TipRanksApr 9 05:40 ET
Buy Rating for PTC Therapeutics Bolstered by Positive Regulatory Prospects and Gene Therapy Advances
TipRanksMar 19 11:05 ET
PTC Therapeutics Analyst Ratings
BenzingaMar 8 11:33 ET
PTC Therapeutics (PTCT) Receives a Hold From RBC Capital
TipRanksMar 8 07:26 ET
Buy Rating Affirmed for PTC Therapeutics Amid Promising Regulatory Progress and Market Opportunity
TipRanksMar 6 06:16 ET
PTC Therapeutics Analyst Ratings
BenzingaMar 1 08:43 ET
RBC Raises Price Target on PTC Therapeutics to $28 From $22, Keeps Sector Perform Rating
MT NewswiresMar 1 08:04 ET
Positive Outlook for PTC Therapeutics: A Comprehensive Buy Rating Justification
TipRanksMar 1 07:15 ET
Downgrade to Sell: PTC Therapeutics Faces Significant Commercial and Competitive Challenges
TipRanksMar 1 06:27 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: BioLife Solutions (BLFS), Cooper Co (COO) and PTC Therapeutics (PTCT)
TipRanksMar 1 05:50 ET
Barclays Keeps Their Hold Rating on PTC Therapeutics (PTCT)
TipRanksMar 1 02:55 ET
PTC Therapeutics: Hold Rating Amidst Revenue Downturn and Regulatory Hurdles
TipRanksFeb 29 22:45 ET
PTC Therapeutics Analyst Ratings
BenzingaJan 26 10:27 ET
No Data
No Data